Drug Delivery Market - Forecasts from 2019 to 2024

January 2019 | 114 pages | ID: D353300F635EN
Knowledge Sourcing Intelligence LLP

Abstracts

The drug delivery market is projected to grow at a CAGR of 7.93% to reach US$1,058.792 billion by 2024, from US$669.691 billion in 2018. Drug delivery is referred to the transfer of drug into the human body either manually or through drug delivery systems or carriers via oral, nasal or skin. These are in high demand due to the growing prevalence of certain diseases which require targeted drug treatments like cancer. Rising R&D investments, growing healthcare expenditures and growing age-related diseases with the increasing elderly population worldwide are also driving the growth of the global drug delivery market in the forecast period. Drug delivery systems/devices/technologies control the rate of drug release and the drug is released to a specific diseased location.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the drug delivery value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the drug delivery market.

Major industry players profiled as part of the report are Pfizer Inc., Insulet Corporation, West Pharmaceutical Services, Inc., Enable Injections and Ascendis Pharma A/S among others.

Segmentation

The drug delivery market has been analyzed through following segments:
By Type
Inhalation Drug Delivery
Injectable Drug Delivery
Nasal Drug Delivery
Oral Drug Delivery
Transdermal Drug Delivery
By Technique
Needle-free injectors
Drug delivery patches
Auto injectors
Others
By Application
Cancer treatment
Infectious diseases treatment
Others
By Geography
North America
USA
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. DRUG DELIVERY MARKET BY TYPE

5.1. Inhalation Drug Delivery
5.2. Injectable Drug Delivery
5.3. Nasal Drug Delivery
5.4. Oral Drug Delivery
5.5. Transdermal Drug Delivery

6. DRUG DELIVERY MARKET BY TECHNIQUE

6.1. Needle-free injectors
6.2. Drug delivery patches
6.3. Auto injectors
6.4. Others

7. DRUG DELIVERY MARKET BY APPLICATION

7.1. Cancer treatment
7.2. Infectious diseases treatment
7.3. Others

8. DRUG DELIVERY MARKET BY GEOGRAPHY

8.1. North America
  8.1.1. USA
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentia
  8.2.3. Others
8.3. Europe
  8.3.1. Germany
  8.3.2. France
  8.3.3. United Kingdom
  8.3.4. Spain
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. Israel
  8.4.3. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. Japan
  8.5.3. South Korea
  8.5.4. India
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competition and Offerings Analysis of Key Vendors
9.2. Recent Investment and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. Pfizer Inc.
10.2. Insulet Corporation
10.3. West Pharmaceutical Services, Inc.
10.4. Enable Injections
10.5. Ascendis Pharma A/S
10.6. Mersana Therapeutics
10.7. Becton, Dickinson and Company
10.8. Consort Medical
10.9. Medtronic
10.10. Boston Scientific Corporation or its affiliates
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER